当前位置 : X-MOL首页行业资讯 › 亚利桑那大学Jianqin Lu课题组招多名药物化学/纳米医学博士后及多名全奖药剂学博士

亚利桑那大学Jianqin Lu课题组招多名药物化学/纳米医学博士后及多名全奖药剂学博士

lujianqin-1.png

Dr. Lu is a John A. and Frances P. Ware Endowed Associate Professor and the Director of Pharmaceutics and Pharmacokinetics Track at R. Ken Coit College of Pharmacy, one of the premier Pharmacy Schools (ranked No. 4 by American Association of Colleges of Pharmacy), at the University of Arizona (UArizona), a member of the Association of American Universities (AAU), a distinction to only 69 North America's premier research institutions. UArizona had more than $955 million total R&D expenditures in 2023, which ranked No. 36 in US by NSF Higher Education Research and Development (HERD) Survey  (https://ncsesdata.nsf.gov/profiles/site?method=rankingBySource&ds=herd  ). 


The overarching goal of the Lu lab strives to develop innovative, safe, and efficacious therapeutics at the interface of drug discovery and delivery, synthetic chemistry, pharmaceutics, nanotechnology, and tumor immunology to address the pressing unmet needs in current cancer, heart, and Alzheimer's diseases therapy and prevention. 


Dr. Lu’s research work has been published in Nature Cancer, Nature Nanotechnology, Nature Communications etc, and has secured > $9 Million research funding including a Maximizing Investigators' Research Award (MIRA) (R35) and 2 R01 grants from the National Cancer Institute of NIH, UArizona Startup and Retention Funds, and other grants from PhRMA Foundation, State of Arizona, UArizona Comprehensive Cancer Center, etc. Visit Lu lab website at: https://www.pharmacy.arizona.edu/person/jianqin-lu and https://wonderfulearth.wixsite.com/jianqinlu 


Recent Representative Publications:

1. Wang, Z., …, Lu, J*. Nature Cancer. In press (2025)

2. Wang, Z#., Li, W#., …, Lu, J*. Nature Communications. 15, 2073 (2024)

3. Wang, Z., …, Lu, J*. Nature Communications. 14, 7235, (2023)

4. Wang, Z., …, Lu, J*. Nature Nanotechnology. 16, 1130–1140 (2021)

4 Postdoctoral Research Associate are available immediately. Candidates should have a strong track record in medicinal chemistry, pharmaceutics, drug delivery, nanomedicine, or immunology.  

2 PhD students with full scholarship is available immediately. Candidates should have training in medicinal chemistry, pharmaceutics, drug delivery, nanomedicine, or pharmacology. Candidates with first author publication(s) in related fields is preferable.

Applicants should send cover letter and CV to Dr. Lu at lu6@arizona.edu



如果篇首注明了授权来源,任何转载需获得来源方的许可!如果篇首未特别注明出处,本文版权属于 X-MOLx-mol.com ), 未经许可,谢绝转载!

阿拉丁
SCI期刊合辑
618助力阅读
EMBO中国科学院期刊分区2025生物学大类-区
加速出版服务0522
科学润色服务0522
药学临床医疗政策
经济金融Q2好刊
中国科学院期刊分区
综合医学期刊
生物医药期刊
文章Top榜单
免疫学SCI期刊
OXFORD特刊征稿进行中
教育领域多学科期刊
化学材料科学SCI期刊
临床期刊 100+
世界读书日助力阅读
老年学Q1区期刊征稿进行中
FEMS Journals历年主题
分享您的投稿习惯
经济学SSCI期刊
英语语言编辑翻译加编辑新
加速出版服务新
1212购书送好礼
Springer旗下全新催化方向高质新刊
动物学生物学
系统生物学合成生物学
专注于基础生命科学与临床研究的交叉领域
传播分子、细胞和发育生物学领域的重大发现
聚焦分子细胞和生物体生物学
图书出版流程
快速找到合适的投稿机会
热点论文一站获取
定位全球科研英才
中国图象图形学学会合作刊
化学所
有机所
中科院
天津理工
广州医科大
清华大学
上海交大
佛罗里达州
首都医学
上海中医
ACS材料视界
down
wechat
bug